Search

The Department of Physical Therapy at the UT Southwestern School of Health Professions offers a 12-month residency-based education program that begins each September. The Neurological Physical Therapy Residency Program supports the American Physical Therapy Association’s vision of providing post-professional clinical training. A residency is defined as a planned program of post entry-level clinical and didactic education that will significantly advance a clinician’s skill and knowledge in the delivery of neurologic physical therapy.

Thank you for considering UT Southwestern's Cardiovascular & Pulmonary Physical Therapy Residency Program. The UTSW CVP Physical Therapy Residency Program accepts one or two residents each year based upon both the application and a personal interview. New graduates are encouraged to apply.

Contact information for the Neurological Physical Therapy Residency Program at UT Southwestern Medical Center (UTSW).

Learn about the costs associated with the Neurological Physical Therapy Residency Program at UT Southwestern (UTSW).

Thank you for considering UT Southwestern's Neurological Physical Therapy Residency Program. The UTSW CVP Physical Therapy Residency Program accepts one or two residents each year based upon both the application and a personal interview. New graduates are encouraged to apply.

UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth – the nation’s fourth-largest metro area – for the sixth consecutive year and ranks among the top hospitals nationally in nine specialties ranging from brain to heart to cancer care.

UT Southwestern Medical Center is one of the 10 best large employers in the United States and among the top 5 health care employers, according to the America’s Best Employers 2022 list compiled by Forbes and Statista.

A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.

Elevated calcium levels in the blood – a complication of kidney cancers known as hypercalcemia – may be successfully treated with a class of medications called HIF-2 inhibitors developed by UT Southwestern Medical Center, a new study shows. The findings, published in Cancer Discovery by a team at UTSW, could offer hope to patients who develop this condition.

A multidisciplinary team at UT Southwestern Medical Center has developed an artificial intelligence (AI)-enabled pipeline that can quickly and accurately extract relevant information from complex, free-text medical records. The team’s novel approach, featured in npj Digital Medicine, could dramatically reduce the time needed to create analysis-ready data for research studies.